Literature DB >> 14669348

Plasma matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 as biomarkers of ulcerative colitis activity.

Alicja Wiercinska-Drapalo1, Jerzy Jaroszewicz, Robert Flisiak, Danuta Prokopowicz.   

Abstract

AIM: Overexpression of mucosal metalloproteinases (MMP) has been demonstrated recently in inflammatory bowel disease. Their activity can be counterbalanced by the tissue inhibitor of metalloproteinases (TIMP). The aim of this study was to evaluate the effect of ulcerative colitis (UC) on MMP-1 and TIMP-1 plasma concentrations, as two possible biomarkers of the disease activity.
METHODS: MMP-1 and TIMP-1 plasma concentrations were measured with an enzyme immunoassay in 16 patients with endoscopically confirmed active UC.
RESULTS: Plasma concentrations of both MMP-1 (13.7 +/- 0.2 ng/ml) and TIMP-1 (799 +/- 140 ng/ml) were significantly elevated in UC patients in comparison to healthy controls (11.9 +/- 0.9 ng/ml and 220 +/- 7 ng/ml respectively). There was no correlation between TIMP-1 and MMP-1 concentrations (r=-0.02). TIMP-1 levels revealed significant positive correlations with scored endoscopic degree of mucosal injury, disease activity index and clinical activity index values as well as C-reactive protein concentration. There was no correlation between MMP-1 and laboratory, clinical or endoscopic indices of the disease activity.
CONCLUSION: These results confirm the role of both MMP-1 and TIMP-1 in the pathogenesis of ulcerative colitis. However only TIMP-1 can be useful as a biomarker of the disease activity, demonstrating association with clinical and endoscopic pictures.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14669348      PMCID: PMC4612067          DOI: 10.3748/wjg.v9.i12.2843

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  26 in total

1.  Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease.

Authors:  E Louis; C Ribbens; A Godon; D Franchimont; D De Groote; N Hardy; J Boniver; J Belaiche; M Malaise
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

Review 2.  Transforming growth factor beta signaling mediators and modulators.

Authors:  C M Zimmerman; R W Padgett
Journal:  Gene       Date:  2000-05-16       Impact factor: 3.688

3.  Increased expression of mRNA for matrix metalloproteinases-1 and -3 and tissue inhibitor of metalloproteinases-1 in intestinal biopsy specimens from patients with coeliac disease.

Authors:  S Daum; U Bauer; H D Foss; D Schuppan; H Stein; E O Riecken; R Ullrich
Journal:  Gut       Date:  1999-01       Impact factor: 23.059

4.  A major role for matrix metalloproteinases in T cell injury in the gut.

Authors:  S L Pender; S P Tickle; A J Docherty; D Howie; N C Wathen; T T MacDonald
Journal:  J Immunol       Date:  1997-02-15       Impact factor: 5.422

5.  Effect of ulcerative colitis treatment on transforming growth factor beta(1) in plasma and rectal mucosa.

Authors:  Alicja Wiercińska-Drapało; Robert Flisiak; Danuta Prokopowicz
Journal:  Regul Pept       Date:  2003-05-15

6.  Matrix metalloproteinase levels are elevated in inflammatory bowel disease.

Authors:  M D Baugh; M J Perry; A P Hollander; D R Davies; S S Cross; A J Lobo; C J Taylor; G S Evans
Journal:  Gastroenterology       Date:  1999-10       Impact factor: 22.682

7.  Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study.

Authors:  K W Schroeder; W J Tremaine; D M Ilstrup
Journal:  N Engl J Med       Date:  1987-12-24       Impact factor: 91.245

8.  Methodologic research on TIMP-1, TIMP-2 detection as a new diagnostic index for hepatic fibrosis and its significance.

Authors:  Qing-He Nie; Yong-Qian Cheng; Yu-Mei Xie; Yong-Xing Zhou; Xian-Guang Bai; Yi-Zhan Cao
Journal:  World J Gastroenterol       Date:  2002-04       Impact factor: 5.742

Review 9.  Growth factors in inflammatory bowel disease.

Authors:  P L Beck; D K Podolsky
Journal:  Inflamm Bowel Dis       Date:  1999-02       Impact factor: 5.325

10.  Suppression of T cell-mediated injury in human gut by interleukin 10: role of matrix metalloproteinases.

Authors:  S L Pender; E J Breese; U Günther; D Howie; N C Wathen; D Schuppan; T T MacDonald
Journal:  Gastroenterology       Date:  1998-09       Impact factor: 22.682

View more
  16 in total

1.  Overexpression of mutant amyloid-β protein precursor and presenilin 1 modulates enteric nervous system.

Authors:  Kendra L Puig; Brianna M Lutz; Siri A Urquhart; Andrew A Rebel; Xudong Zhou; Gunjan D Manocha; MaryAnn Sens; Ashok K Tuteja; Norman L Foster; Colin K Combs
Journal:  J Alzheimers Dis       Date:  2015       Impact factor: 4.472

2.  Increased protein expression of matrix metalloproteinases -1, -3, and -9 and TIMP-1 in patients with gluten-sensitive enteropathy.

Authors:  Bashir M Mohamed; Conleth Feighery; Jacinta Kelly; Christian Coates; Una O'Shea; Louise Barnes; Mohamed Abuzakouk
Journal:  Dig Dis Sci       Date:  2006-10       Impact factor: 3.199

3.  Expression of matrix metalloproteinase-1 and tissue inhibitor of metalloproteinase-1 in ulcerative colitis.

Authors:  Ying-De Wang; Pei-Yun Yan
Journal:  World J Gastroenterol       Date:  2006-10-07       Impact factor: 5.742

4.  Plasma interleukin-18 reflects severity of ulcerative colitis.

Authors:  Alicja Wiercinska-Drapalo; Robert Flisiak; Jerzy Jaroszewicz; Danuta Prokopowicz
Journal:  World J Gastroenterol       Date:  2005-01-28       Impact factor: 5.742

5.  Are Matrix Metalloproteinase-9 and Tissue Inhibitor of Metalloproteinase-1 Useful as Markers in Diagnostic Management of Children with Newly Diagnosed Ulcerative Colitis?

Authors:  Aleksandra Czajkowska; Katarzyna Guzinska-Ustymowicz; Anna Pryczynicz; Dariusz Lebensztejn; Urszula Daniluk
Journal:  J Clin Med       Date:  2022-05-09       Impact factor: 4.964

Review 6.  Digestive Inflammation: Role of Proteolytic Dysregulation.

Authors:  Vincent Mariaule; Aicha Kriaa; Souha Soussou; Soufien Rhimi; Houda Boudaya; Juan Hernandez; Emmanuelle Maguin; Adam Lesner; Moez Rhimi
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

7.  A local imbalance between MMP and TIMP may have an implication on the severity and course of appendicitis.

Authors:  Anna Solberg; Lena Holmdahl; Peter Falk; Ingrid Palmgren; Marie-Louise Ivarsson
Journal:  Int J Colorectal Dis       Date:  2008-03-18       Impact factor: 2.571

Review 8.  Impact of proteolytic enzymes in colorectal cancer development and progression.

Authors:  László Herszényi; Loránd Barabás; István Hritz; Gábor István; Zsolt Tulassay
Journal:  World J Gastroenterol       Date:  2014-10-07       Impact factor: 5.742

9.  Expression of matrix metalloproteinases in patients with Wegener's granulomatosis.

Authors:  V Bjerkeli; B Halvorsen; J K Damås; I Nordøy; A Yndestad; P Aukrust; S S Frøland
Journal:  Ann Rheum Dis       Date:  2004-12       Impact factor: 19.103

Review 10.  The behavior of matrix metalloproteinases and their inhibitors in colorectal cancer.

Authors:  László Herszényi; István Hritz; Gábor Lakatos; Mária Zsófia Varga; Zsolt Tulassay
Journal:  Int J Mol Sci       Date:  2012-10-16       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.